Domańska-Poboża Julia, Wisłowska Małgorzata
Rheumatology Clinic, National Institute of Geriatric, Rheumatology and Rehabilitation in Warsaw, Poland.
Reumatologia. 2025 Feb 10;63(2):116-130. doi: 10.5114/reum/195012. eCollection 2025.
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease characterized by joint inflammation, degradation of cartilage and bone, and potential systemic effects. This paper provides a comprehensive historical overview of RA treatment, tracing the evolution from ancient empirical methods to modern targeted therapies. Advancements in the understanding of RA's immunopathology have led to the development of conventional, biological, and targeted disease-modifying antirheumatic drugs, including tumor necrosis factor α inhibitors and Janus kinase inhibitors. These innovations have been pivotal in transforming RA management, allowing for more personalized and effective treatment strategies. The historical progression in RA treatment reflects a shift from symptomatic management to targeted interventions aimed at the underlying mechanisms of the disease. This shift has not only improved clinical outcomes but also enhanced the quality of life for those affected by RA, underscoring the importance of ongoing research and adaptation of therapeutic strategies.
类风湿性关节炎(RA)是一种慢性全身性炎症性疾病,其特征为关节炎症、软骨和骨降解以及潜在的全身影响。本文全面回顾了RA治疗的历史,追溯了从古代经验方法到现代靶向治疗的演变。对RA免疫病理学认识的进步导致了传统、生物和靶向改善病情抗风湿药物的发展,包括肿瘤坏死因子α抑制剂和Janus激酶抑制剂。这些创新在改变RA管理方面起到了关键作用,使更个性化和有效的治疗策略成为可能。RA治疗的历史进程反映了从症状管理到针对疾病潜在机制的靶向干预的转变。这一转变不仅改善了临床结果,还提高了RA患者的生活质量,凸显了持续研究和调整治疗策略的重要性。